Entwicklung eines Prototyps für die Point-of-Care-Diagnostik von Blutammoniak
Beschreibung
Hyperammonemia and associated neurological manifestations (hepatic encephalopathy) lead to coma and death and incur high costs. It affects 30-45% of cirrhotic patients. A novel portable point of care device based on pH-gradient polymersomes for daily monitoring of ammonia will alleviate the burdens.
Eckdaten
Projektleitung
Stellv. Projektleitung
Projektteam
Christian Grossmann Aybar, Raphael Hagen, Dr. Fabrizio Spano, Jan Zwicky
Projektpartner
Versantis AG
Projektstatus
laufend, gestartet 04/2022
Institut/Zentrum
Institute of Computational Physics (ICP)
Drittmittelgeber
Innosuisse
Projektvolumen
567'592 CHF
